R1	Has_value Arg1:T2 Arg2:T1	
*	OR T6 T3
R2	Has_value Arg1:T4 Arg2:T5	
R3	Subsumes Arg1:T6 Arg2:T4	
*	OR T12 T13
R4	Has_temporal Arg1:T12 Arg2:T11	
R5	Has_value Arg1:T15 Arg2:T16	
R6	Has_multiplier Arg1:T15 Arg2:T17	
R7	multi Arg1:T21 Arg2:T22	
R8	Has_index Arg1:T20 Arg2:T21	
R9	Has_temporal Arg1:T18 Arg2:T20	
R10	Has_value Arg1:T18 Arg2:T19	
R11	Has_value Arg1:T23 Arg2:T24	
*	OR T12 T18 T15 T23
R12	Has_temporal Arg1:T8 Arg2:T10	
R13	Has_multiplier Arg1:T12 Arg2:T9	
R14	AND Arg1:T8 Arg2:T12	
R15	Has_value Arg1:T27 Arg2:T28	
R16	Has_value Arg1:T29 Arg2:T30	
*	OR T31 T33 T34
R17	Has_multiplier Arg1:T31 Arg2:T32	
R18	Has_temporal Arg1:T31 Arg2:T35	
T1	Value 14 32	18 to 80 years old
T2	Person 9 13	aged
T3	Condition 48 55	obesity
T4	Measurement 57 60	BMI
T5	Value 61 70	=25 kg/m2
T6	Condition 34 44	Overweight
T8	Condition 95 110	type 2 diabetes
T9	Multiplier 123 135	at least one
T10	Temporal 73 81	Previous
T11	Temporal 166 173	current
T12	Drug 189 212	oral antidiabetic drugs
T13	Drug 220 227	insulin
T15	Measurement 234 249	fasting glucose
T16	Value 256 271	above 126 mg/dl
T17	Multiplier 272 295	on at least 2 occasions
T18	Measurement 300 319	blood glucose level
T19	Value 371 402	equal to or more than 200 mg/dl
T20	Temporal 320 367	at 2 hours after an oral glucose tolerance test
T21	Reference_point 337 367	an oral glucose tolerance test
T22	Procedure 340 367	oral glucose tolerance test
T23	Measurement 412 445	glycated hemoglobin (HbA1c) level
T24	Value 446 453	> 6.5 %
T26	Condition 477 497	diabetic nephropathy
T27	Measurement 506 538	urinary albumin/creatinine ratio
T28	Value 539 547	>30 mg/g
T29	Measurement 555 591	estimated glomerular filtration rate
T30	Value 592 623	more than 20 ml/min per 1.73 m2
T31	Drug 657 697	angiotensin-converting enzyme inhibitors
T32	Multiplier 641 653	stable doses
T33	Drug 699 731	angiotensin II receptor blockers
T34	Drug 735 758	anti-aldosterone agents
T35	Temporal 759 781	in the last four weeks
